Related Experiment Video
Updated: Nov 24, 2025
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
COVID-19 Treatment at a Glance
Hüseyin Arıkan1, Dilek Karadoğan2, Fatma Tokgöz Akyıl3
1Department of Internal Medicine, Intensive Care Unit, Yüzüncü Yıl University, Dursun Odabaş Medical Center, Van, Turkey.
Abstract:
As coronavirus disease 2019 (COVID-19) spreads across the world, the ongoing clinical trials are leading to a big race worldwide to develop a treatment that will help control the pandemic. Unfortunately, COVID-19 does not have any known effective treatment with reliable study results yet. In this pandemic, there is not a lot of time to develop a new specific agent because of the rapid spread of the disease. The process of developing a vaccine is long and requires hard work. Although the pathophysiology of the disease is not fully understood, some of the proposed treatment alternatives are based on old evidence and some have been used with the idea that they might work owing to their mechanism of action. The efficacy, reliability, and safety of the currently available treatment alternatives are therefore a matter of debate. Currently, the main therapies used in the treatment of COVID-19 are antiviral drugs and chloroquine/hydroxychloroquine. Other proposed options include tocilizumab, convalescent plasma, and steroids, but the mainstay of the treatment in intensive care units remains supportive therapies.
Insights
Developing effective treatments for coronavirus disease 2019 (COVID-19) is critical. Current COVID-19 therapies, including antivirals and hydroxychloroquine, are debated for their safety and effectiveness, with supportive care remaining key in intensive units.
Area of Science:
- Infectious Diseases
- Virology
- Critical Care Medicine
Background:
- The rapid global spread of coronavirus disease 2019 (COVID-19) necessitates urgent development of effective treatments.
- Currently, no definitive treatment with robust study results exists for COVID-19.
- Understanding the pathophysiology of COVID-19 is incomplete, complicating treatment development.
Purpose of the Study:
- To review the current landscape of COVID-19 treatments.
- To evaluate the efficacy, reliability, and safety of proposed and existing therapeutic options.
- To highlight the role of supportive therapies in managing severe COVID-19 cases.
Main Methods:
- Review of existing clinical trial data and scientific literature on COVID-19 treatments.
- Analysis of proposed therapeutic agents, including antivirals, chloroquine/hydroxychloroquine, tocilizumab, convalescent plasma, and steroids.
- Assessment of the role of supportive care in intensive care unit settings.
Main Results:
- The efficacy and safety of many COVID-19 treatment alternatives remain under debate.
- Antiviral drugs and chloroquine/hydroxychloroquine are primary therapeutic strategies.
- Supportive therapies are the cornerstone of treatment for patients in intensive care units.
Conclusions:
- There is an urgent need for evidence-based treatments for COVID-19.
- The current therapeutic options for COVID-19 require further rigorous investigation.
- Supportive care remains essential for managing critically ill COVID-19 patients while definitive treatments are sought.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:16Therapeutic Drug Monitoring: Overview and Classification
01:16Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...